Results 171 to 180 of about 335,762 (303)

Attenuation of Influenza a Virus into Live Vaccines Through C-End Degrons. [PDF]

Adv Sci (Weinh)
Wang P, Li L, Chen Y, Tong L, Li Z, Yu R, Shen Q, Wang Q, Hou J, Zhang Q, Si X, Wang N, Zhou D, Tian WX, Si L.   +14 more
europepmc   +1 more source

Poliovirus vaccine—live

, 2013
Roland W. Sutter, Olen M. Kew, Stephen L. Cochi, R. Bruce Aylward   +3 more
openaire   +1 more source

Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation

Advanced Science, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale mediators of intercellular communication with diverse molecular cargoes that reflect their cell of origin. Advances in isolation, detection, and single‐particle analytics have revealed increasing molecular and functional heterogeneity, while exposing limitations in how EV identity and activity are ...
David J. Lundy, Zoe L. Chau, Sheng‐You Chen, Nanami Fujisawa, John J. Hill, Barnett M. Hsu, Joanne K. Liu, Karol W. Mai, James J. Lai   +8 more
wiley   +1 more source

Decision-Making Regarding the Administration of Live Vaccines to Patients With a FOXN1 Heterozygous Missense Variant. [PDF]

Pediatr Int
Yasutomi-Sakai M, Isozaki Y, Okuno T, Yuasa M, Ohshima Y.   +4 more
europepmc   +1 more source

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB^-CTE Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study. [PDF]

Iran J Parasitol, 2020
Taslimi Y, Zahedifard F, Taheri T, Doroud D, Latif Dizaji S, Saljoughian N, Rafati S.   +6 more
europepmc   +1 more source

Influenza vaccine—live

, 2013
Catherine J. Luke, Seema S. Lakdawala, Kanta Subbarao   +2 more
openaire   +1 more source

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

Advanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu, Mengtao Sun, Lusheng Li, Jieqiong Wang, Shibiao Wan   +4 more
wiley   +1 more source

Synergistic Enhancement of Humoral and Cellular Immunity in Attenuated Live Vaccines Using Chemical Nanoadjuvants: Evaluation of Sustained-Release Formulations. [PDF]

Vet Sci
Shi J, Liu C, Li C, Li J.
europepmc   +1 more source

Aptamer‐Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer

Advanced Science, EarlyView.
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang, Xuan Wang, Xinfeng Dai, Linxin Tian, Wencheng Shen, Xueliang Liu, Wei Xue, Jiahua Pan, Yu Yang   +8 more
wiley   +1 more source

Field Investigation Evaluating the Efficacy of Porcine Reproductive and Respiratory Syndrome Virus Type 2 (PRRSV-2) Modified Live Vaccines in Nursery Pigs Exposed to Multiple Heterologous PRRSV Strains. [PDF]

Animals (Basel)
Mebumroong S, Lin H, Jermsutjarit P, Tantituvanont A, Nilubol D.   +4 more
europepmc   +1 more source